Proteome of platelets in patients with coronary artery disease

Experimental Hematology

Volumn 38, Issue 5, 2010, Pages 341-350

  Banfi, Cristina ^a,b   Brioschi, Maura ^a,b   Marenzi, Giancarlo ^a,b   De Metrio, Monica ^a,b   Camera, Marina ^a,b   Mussoni, Luciana ^b   Tremoli, Elena ^a,b  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIN; GAMMA ACTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KHELLIN; LACTATE DEHYDROGENASE; OXOGLUTARATE DEHYDROGENASE; PLECKSTRIN; PROTEASOME; PROTEOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CYTOSKELETON; DIABETES MELLITUS; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; ENERGY METABOLISM; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERTENSION; LEUKOCYTE COUNT; MALE; MASS SPECTROMETRY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NUCLEOTIDE SEQUENCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; STABLE ANGINA PECTORIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TWO DIMENSIONAL ELECTROPHORESIS;

ACTINS; ACUTE CORONARY SYNDROME; AGED; AMINO ACID SEQUENCE; ANGINA PECTORIS; BLOOD PLATELETS; BLOOD PROTEINS; FEMALE; HUMANS; KETOGLUTARATE DEHYDROGENASE COMPLEX; L-LACTATE DEHYDROGENASE; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; PROTEOME;

ANGINA;

EID: 77951480415     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.03.001     Document Type: Article

References (40)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992, 326:310-318.
2. Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005, 111:3481-3488.
3. Gawaz M. The evolving science of atherothrombotic disease. Eur Heart J Suppl 2008, 10:I4-I7.
4. Davì G., Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007, 357:2482-2494.
5. Blackstock W.P., Weir M.P. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 1999, 17:121-127.
6. Watson S.P., Bahou W.F., Fitzgerald D., Ouwehand W., Rao A.K., Leavitt A.D. ISTH Platelet Physiology Subcommittee. Mapping the platelet proteome: a report of the ISTH Platelet 7. Physiology Subcommittee. J Thromb Haemost 2005, 3:2098-2101.
7. Gnatenko D.V., Dunn J.J., McCorkle S.R., Weissmann D., Perrotta P.L., Bahou W.F. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003, 101:2285-2293.
8. Howes J.M., Keen J.N., Findlay J.B., Carter A.M. The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease. Diab Vasc Dis Res 2008, 5:205-212.
9. Maurer-Spurej E., Kahr W.H., Carter C.J., Pittendreigh C., Cameron M., Cyr T.D. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets 2008, 19:342-351.
10. Springer D.L., Miller J.H., Spinelli S.L., et al. platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res 2009, 8:2261-2272.
11. Marcus K., Moebius J., Meyer H.E. Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets. Anal Bioanal Chem 2003, 376:973-993.
12. Brambilla M., Camera M., Colnago D., et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol 2008, 28:947-953.
13. Gelosa P., Banfi C., Brioschi M., et al. S 35171 exerts protective effects in spontaneously hypertensive stroke-prone rats by preserving mitochondrial function. Eur J Pharmacol 2009, 604:117-124.
14. Banfi C., Brioschi M., Barcella S., et al. Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme. Proteomics 2009, 9:1344-1352.
15. Heller M., Ye M., Michel P.E., et al. Added value for tandem mass spectrometry shotgun proteomics data validation through isoelectric focusing of peptides. J Proteome Res 2005, 4:2273-2282.
16. Szutowicz A., Lysiak W., Angielski S. The effect of (-)hydroxycitrate on pyruvate metabolism in rat brain synaptosomes. J Neurochem 1977, 29:375-378.
17. Banfi C., Mussoni L., Risé P., et al. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type-1 in cultured HepG2 cells. Circ Res 1999, 85:208-217.
18. Tyers M., Rachubinski R.A., Stewart M.I., et al. Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature 1988, 333:470-473.
19. Zappacosta B., De Sole P. Lactic dehydrogenase activity of platelet subpopulations during pregnancy. Arch Gynecol Obstet 1992, 251:165-169.
20. Zoli A., Zappacosta B., Altomonte L., et al. Platelet lactate dehydrogenase activity in systemic lupus erythematosus: correlation with anticardiolipin antibodies. J Rheumatol 1995, 22:649-653.
21. Zappacosta B., De Sole P., Rossi C., Marra G., Ghirlanda G., Giardina B. Lactate dehydrogenase activity of platelets in diabetes mellitus. Eur J Clin Chem Clin Biochem 1995, 33:487-489.
22. Cesar J.M., Pallares E., Rubí J., Navarro J.L. Lactate production by thrombin-activated platelets of patients with primary thrombocytemia. Thromb Res 2006, 118:335-339.
23. Leoncini G., Maresca M., Armani U., Piana A. Lactate overproduction in platelets of subjects affected with myeloproliferative disorders. Scand J Haematol 1985, 35:229-332.
24. Michno A., Skibowska A., Raszeja-Specht A., Cwikowska J., Szutowicz A. The role of adenosine triphosphate citrate lyase in the metabolism of acetyl coenzyme a and function of blood platelets in diabetes mellitus. Metabolism 2004, 53:66-72.
25. Michno A., Raszeja-Specht A., Jankowska-Kulawy A., Pawelczyk T., Szutowicz A. Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons. Clin Chem 2005, 51:1673-1682.
26. Craik J.D., Stewart M., Cheeseman C.I. GLUT-3 (brain-type) glucose transporter polypeptides in human blood platelets. Thromb Res 1995, 79:461-469.
27. Landon F., Huc C., Thomé F., Oriol C., Olomucki A. Human platelet actin. Evidence of beta and gamma forms and similarity of properties with sarcomeric actin. Eur J Biochem 1977, 81:571-577.
28. Villa P.G., Henzel W.J., Sensenbrenner M., Henderson C.E., Pettmann B. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci 1998, 111:713-722.
29. Cohen Z., Davis-Gorman G., McDonagh P.F., Ritter L. Caspase inhibition of platelet activation. Blood Coagul Fibrinolysis 2008, 19:305-309.
30. Fox J.E. Cytoskeletal proteins and platelet signaling. Thromb Haemost 2001, 86:198-213.
31. de Hostos E.L., Bradtke B., Lottspeich F., Guggenheim R., Gerisch G. Coronin, an actin binding protein of Dictyostelium discoideum localized to cell surface projections, has sequence similarities to G protein beta subunits. EMBO J 1991, 10:4097-4104.
32. Uetrecht A.C., Bear J.E. Coronins: the return of the crown. Trends Cell Biol 2006, 16:421-426.
33. Humphries C.L., Balcer H.I., D'Agostino J.L., et al. Direct regulation of Arp2/3 complex activity and function by the actin binding protein coronin. J Cell Biol 2002, 159:993-1004.
34. Cai L., Marshall T.W., Uetrecht A.C., Schafer D.A., Bear J.E. Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. Cell 2007, 128:915-929.
35. Li Z., Kim E.S., Bearer E.L. Arp2/3 complex is required for actin polymerization during platelet shape change. Blood 2002, 99:4466-4474.
36. Ostrowska H., Ostrowska J.K., Worowski K., Radziwon P. Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28. A preliminary report. Platelets 2003, 14:151-157.
37. Kisselev A.F., Goldberg A.L. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 2001, 8:739-758.
38. Ma A.D., Abrams C.S. Pleckstrin homology domains and phospholipid-induced cytoskeletal reorganization. Thromb Haemost 1999, 82:399-406.
39. García A., Senis Y.A., Antrobus R., et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 2006, 6:5332-5343.
40. Gabbeta J., Yang X., Sun L., McLane M.A., Niewiarowski S., Rao A.K. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. Blood 1996, 87:1368-1376.